<DOC>
	<DOCNO>NCT01051076</DOCNO>
	<brief_summary>The purpose study evaluate whether concentrate contain FVIII von Willebrand Factor ( VWF ) give high dose induce immune tolerance subject already experience failed ITI VWF-free FVIII concentrate . The treatment study expect last 33 month .</brief_summary>
	<brief_title>Rescue Immunotolerance Study Induction Immune Tolerance ( ITI ) -Experienced Patients ( RES.I.S.T . Experienced )</brief_title>
	<detailed_description>The presence Factor VIII ( FVIII ) inhibitor prevents FVIII infusion work properly make treatment bleed episode difficult . Having inhibitor serious life-threatening complication patient Hemophilia . The usual treatment patient FVIII inhibitor involve call `` immune tolerance induction '' ( ITI ) . Immune Tolerance mean body accept infuse FVIII FVIII effective control bleeds . ITI involve give high dos FVIII regularly inhibitor disappear . This treatment always effective . The inhibitor persist 1 5 patient undergo ITI . There 2 type FVIII concentrate : FVIII concentrate derive human plasma , contain VWF , concentrate FVIII without VWF . Both type concentrate commonly use induce immune tolerance patient Hemophilia A. Retrospective study subject treated VWF contain Factor VIII concentrate fail ITI pure factor VIII concentrate , show tolerance achieve large percentage patient . This study access prospectively whether treatment FVIII concentrate contain VWF give high dose ( 200 unit per kilogram ) daily 33 month able induce immune tolerance previous attempt concentrate contain FVIII fail .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<criteria>1. severe hemophilia A ( FVIII &lt; 1 % ) high respond inhibitor ( peak level &gt; 5 BU ) 2. male , age ; 3. inhibitor level study enrollment ; 4. ability willingness participate study ; 5. previous ITI course least 9 month VWFfree FVIII concentrate dosage , recombinant FVIII and/or monoclonally purify FVIII . 1. concomitant systemic treatment immunosuppressive drug ; 2. concomitant experimental treatment ; 3. previous history myocardial infarction and/or cerebral stroke</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ITI</keyword>
	<keyword>Haemophilia A</keyword>
	<keyword>Inhibitors</keyword>
	<keyword>Failed ITI</keyword>
	<keyword>VWF/FVIII concentrate</keyword>
</DOC>